Mutational landscape in Waldenström macroglobulinemia evaluated using a next-generation sequencing lymphoma panel in routine clinical practice-Reference-Cited by-同舟云学术

Mutational landscape in Waldenström macroglobulinemia evaluated using a next-generation sequencing lymphoma panel in routine clinical practice

Published:2024-02-10 Issue:6 Volume:65 Page:758-767
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Østergaard Simon¹,Schejbel Lone²,Breinholt Marie Fredslund²,Pedersen Mette Ølgod¹³,Hammer Troels⁴,Munksgaard Lars⁵,Nørgaard Peter²⁶,Høgdall Estrid²³,Gjerdrum Lise Mette Rahbek¹³,Nielsen Torsten Holm⁴⁵⁷^ORCID

Affiliation:

1. Department of Pathology, Zealand University Hospital, Roskilde, Denmark

2. Department of Pathology, Copenhagen University Hospital, Herlev, Denmark

3. Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark

4. Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

5. Department of Hematology, Zealand University Hospital, Roskilde, Denmark

6. Department of Pathology, Hvidovre Hospital, Hvidovre, Denmark

7. Danish Medicines Agency, Copenhagen, Denmark

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2024.2313623

Reference43 articles.

1. Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia

2. The genomic landscape of Waldenström macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis

3. CXCR4 in Waldenström’s Macroglobulinema: chances and challenges

4. MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia

5. 6q deletion in Waldenström macroglobulinaemia negatively affects time to transformation and survival